Canada Markets closed
  • S&P/TSX

    20,633.27
    -128.76 (-0.62%)
     
  • S&P 500

    4,538.43
    -38.67 (-0.84%)
     
  • DOW

    34,580.08
    -59.71 (-0.17%)
     
  • CAD/USD

    0.7786
    -0.0022 (-0.2826%)
     
  • CRUDE OIL

    66.22
    -0.28 (-0.42%)
     
  • BTC-CAD

    63,080.28
    +2,888.80 (+4.80%)
     
  • CMC Crypto 200

    1,367.14
    -74.62 (-5.18%)
     
  • GOLD FUTURES

    1,782.10
    +21.40 (+1.22%)
     
  • RUSSELL 2000

    2,159.31
    -47.02 (-2.13%)
     
  • 10-Yr Bond

    1.3430
    -0.1050 (-7.25%)
     
  • NASDAQ

    15,085.47
    -295.85 (-1.92%)
     
  • VOLATILITY

    30.67
    +2.72 (+9.73%)
     
  • FTSE

    7,122.32
    -6.89 (-0.10%)
     
  • NIKKEI 225

    28,029.57
    +276.20 (+1.00%)
     
  • CAD/EUR

    0.6878
    -0.0027 (-0.39%)
     

UPDATE 1-U.S. has administered nearly 414 mln doses of COVID-19 vaccines

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

(Updates with number of doses distributed)

Oct 24 (Reuters) - The United States has administered 413,645,478 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 503,493,015 doses, the U.S. Centers for Disease Control and Prevention said.

The number of doses administered is up from 412,856,169 vaccine doses the CDC said had gone into arms by Saturday.

However, the number of doses delivered were marginally down from the numbers reported on Saturday. The CDC has previously said that revisions made by vaccine providers can result in cumulative delivery data dropping between certain days. The CDC did not immediately respond to a request for comment.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech as well as Johnson & Johnson's one-shot vaccine.

About 12.88 million people have received a booster dose of either Pfizer or Moderna's vaccine since Aug. 13, when the United States authorized a third dose of the vaccines for people with compromised immune systems who are likely to have weaker protection from the two-dose regimens. (Reporting by Ann Maria Shibu in Bengaluru; Editing by Mark Porter)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting